References
- AdelmanLCAdelmanJUFreemanMC2004Pharmacoeconomics: The cost of prophylactic migraine treatmentsHeadache441050515546274
- AllaisGBussoneGDe LorenzoC2005Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospectsNeurol Sci26S125915926009
- AsakuraKKanemasaTMinagawaK2000Alpha-eudesmol, a P/Q-type Ca2+ channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglionBrain Res8739410110915814
- AshkenaziASilbersteinSD2004Botulinum toxin and other new approaches to migraine therapyAnnu Rev Med555051814746533
- AyajikiKOkamuraTTodaN1997Flunarizine, an anti-migraine agent, impairs nitroxidergic nerve function in cerebral arteriesEur J Pharmacol32949539218683
- BigalMELiptonRBStewartWF2004The epidemiology and impact of migraineCurr Neurol Neurosci Rep49810414984680
- BinderWJBrinMFBlitzerA2000Otolaryngol Head Neck Surg1236697611112955
- BrandesJL2005Practical use of topiramate for migraine preventionHeadache45S667315833092
- BrandesJLSaperJRDiamondM2004Topiramate for migraine prevention, a randomized controlled trialJAMA2919657314982912
- BrinMFSwopeDMO’BrienC2000Botox for migraine: double-blind, placebo-controlled, region-specific evaluation [abstract]Cephalalgia204212 (Abstract 386)
- ColomboBAnnovazziPOLComiG2004Therapy of primary headaches: the role of antidepressantsNeurol Sci25S171515549531
- CutrerFM2001Antiepileptic drugs: how they work in headacheHeadache41S31011903534
- CutrerFMLimmrothVMoskowitzMA1997Possible mechanisms of valproate in migraine prophylaxisCephalalgia17931009137844
- D’AmicoD2004Treatment strategies in migraine patientsNeurol Sci25S242315549547
- DaviesGMSantanelloNLiptonR2000Determinants of patient satisfaction with migraine therapyCephalalgia205546011075838
- DienerHKatasarvaZ2001Analgesic/abortive overuse and misuse in chronic daily headacheCurr Pain and Headache Rep554550
- DienerHTfelt-HansenPDahlofC2004Topiramate in migraine prophylaxis, Results from placebo-controlled trial with propranolol as an active controlJ Neurol2519435015316798
- DrakeMEGreathouseNIRennerJB2004Open-label zonisamide for refractory migraineClin Neuropharmacol272788015613932
- DurhamPLCadyRCadyR2004Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type a: implications for migraine therapyHeadache44354314979881
- EvansRWLiptonRB2001Topics in migraine management, a survey of headache specialists highlights some controversiesNeurol Clin1912111471758
- EversSMylecharaneEJOlesenJ2006Nonsteroidal anti-inflammatory and miscellaneous drugs in migraine prophylaxisThe headaches3rd edPhiladelphia, PA, USALippincott Williams and Wilkins55366
- EversSVollmer-HaaseJSchwaagS2004Botulinum toxin A in the prophylactic treatment of migraine-a randomized, double-blind, placebo-controlled studyCephalalgia248384315377314
- FreitagFGCollinsSDCarlsonHA2002A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxisNeurology581652912058094
- GoadsbyPJ2004Post-triptan era for the treatment of acute migraineCurr Pain and Headache Rep83938
- GoadsbyPJRamadanNHOlesenJ2006Potential new drugs for acute and prophylactic treatment of migrainesThe headaches3rd edPhiladelphia, PA, USALippincott Williams and Wilkins56976
- GranellaFAllaisGBenedettoC2003Cyclo-oxygenase-2 inhibitors as short-term prophylaxis of menstrually related migraine. A pilot study [abstract]Cephalalgia23731
- HuXHO’DonnellFKunkelRS2000Survey of migraineurs referred to headache specialists: Care, satisfaction, and outcomesNeurology55141310891927
- [IHSCC] International Headache Society Classification Committee2004International classification of headache disorders, 2nd edCephalalgia24Suppl 125
- KrymchantowskiAVBarbosaJS2000Prednisone as initial treatment of analgesic-induced daily headacheCephalalgia201071310961766
- LanceJWGoadsbyPJLanceJW2005Migraine: treatmentMechanism and management of headache7th edPhiladelphia, PAElsevier Butterworth Heinemann12362
- LaunerLJTerwindtGMFerrariMD1999The prevalence and characteristics of migraine in a population-based cohort: The GEM StudyNeurology535374210449117
- LinJWangPChenC2005Homozygous deletion genotype of angiotensin converting enzyme confers protection agains migraine in manActa Neurol Taiwan14120516252613
- LiptonRBStewartWFDiamondS2001Prevalence and burden of migraine in the United States: data from the American Migraine Study IIHeadache416465711554952
- LoderEBiondiD2005General principles of migraine management: the changing role of preventionHeadache45S334715833089
- MassiouHMacGregorEA2000Evolution and treatment of migraine with oral contraceptivesCephalalgia20170410997770
- MathewNT2001Antiepileptic drugs in migraine preventionHeadache41S182411903536
- MathewNTEvansRW2005Preventive treatment of migraineHandbook of headache2nd edPhiladelphia, PALippincott Williams and Wilkins88112
- MathewNTKailasamJMeadorsL2002Prophylaxis of migraine, and cluster headache with topiramateHeadache4279680312390644
- MathewNTKurmanRPerezF1990Drug induced refractory headache – clinical features and managementHeadache3063482272811
- MathewNTRapoportASaperJ2001Efficacy of gabapentin in migraine prophylaxisHeadache411192811251695
- MoschianoFAllaisGGrazziL2005Naratriptan in the short-term prophylaxis of pure menstrual migraineNeurol Sci26S162615926020
- NewmanLCLiptonRBLayCL1998A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraineNeurology5130799674831
- NewmanLMannixLKLandyS2001Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled studyHeadache412485611264684
- PatrickDLMartinMLBushnellDM2003Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratingsClin Ther2529203514693316
- RamadanNM2004Prophylactic migraine therapy: mechanisms and evidenceCurr Pain and Headache Rep8915
- RamadanNM2005Targeting therapy for migraine, what to treat?Neurology64Suppl 2S4815911784
- RasmussenBKStewartWFOlesenJ2000Epidemiology of migraineThe headaches2nd edPhiladelphia, PA, USALippincott Williams and Wilkins230
- SangCNRamadanNMWallihanRG2004LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraineCephalalgia2459660215196302
- SawynokJEsserMJReidAR2001Antidepressants as analgesics: an overview of central and peripheral mechanisms of actionJ Psychiatry Neurosci2621911212590
- SchoenenJMaertens de NoordhoutA1986Contingent negative variation and efficacy of beta-blocking agents in migraineCephalalgia6229332879628
- SchraderHStovnerLJHeldeG2001Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover studyBMJ3221511141128
- SilbersteinSD1996Divalproex sodium in headache: literature review and clinical guidelinesHeadache36547558916563
- SilbersteinSD2004Topiramate in migraine prevention: evidence-based medicine from clinical trialsNeurol Sci24S244515549548
- SilbersteinSD2005aPreventive treatment of headachesCurr Opin Neurol182899215891414
- SilbertsteinSD2005bTopiramate in migraine preventionHeadache45S5765
- SilbersteinSDCollinsSD1999Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term studyHeadache396334311284461
- SilbersteinSDElkindAHSchreiberC2004A randomized trial of frovatriptan for the intermittent prevention of menstrual migraineNeurology63261915277618
- SilbersteinSDLiptonRBGoadsbyPJSilbersteinSD2002Migraine: diagnosis and treatmentHeadache in Clinical Practice2nd edLondon, UKMartin Dunitz Ltd69111
- SilbersteinSMathewNSaperJ2000Botulinum toxin type A as a migraine preventive treatmentHeadache404455010849039
- SilbersteinSDNetoWSchmittJ2004Topiramate in migraine prevention, results of a large controlled trialArch Neurol61490515096395
- SilbersteinSDSaperJRFreitagFGSilbersteinSD2001Migraine: diagnosis and treatmentWolff’s headache and other head pain7th edNew YorkOxford University Pr121237
- SilbersteinSDTfelt-HansenPOlesenJ2006Antiepileptic drugs in migraine prophylaxisThe headaches3rd edPhiladelphia, PA, USALippincott Williams and Wilkins53944
- SmithTRStonemanJ2004Medication overuse headache from antimigraine therapy, clinical features, pathogenesis and managementDrugs6425031415516151
- Tfelt-HansenPRolanPOlesenJ2006B-adrenoceptor blocking drugs in migraine prophylaxisThe headaches3rd edPhiladelphia, PA, USALippincott Williams and Wilkins51928
- TodaNTfelt-HansenPOlesenJ2000Calcium antagonists in migraine prophylaxisThe headaches2nd edPhiladelphia, PA, USALippincott Williams and Wilkins47782
- TodaNTfelt-HansenPOlesenJ2006Calcium antagonists in migraine prophylaxisThe headaches3rd edPhiladelphia, PA, USALippincott Williams and Wilkins53944
- TrapaniGDMeiDMazzaS2000Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled studyClin Ther1511458
- TronvikWStovnerLJHeldeG2003Prophylactic treatment of migraine with an angiotensin II receptor blockerJAMA28965912503978
- [USHC] United States Headache Consortium2000Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review)Report of the Quality Standards Subcommittee of the American Academy of NeurologyAmerican Academy of Neurology111
- WaeberCMoskowitzMA2003Therapeutic implications of central and peripheral neurologic mechanisms in migraineNeurology61S92014581653
- WelchKMA2003Contemporary concepts of migraine pathogenesisNeurology61S2814581652
- WelchKM2005Brain hyperexcitability: the basis for antiepileptic drugs in migraine preventionHeadache45S253215833087
- YoungWBSiowHCSilbersteinSD2004Anticonvulsants in migraineCurr Pain and Headache Rep824450